Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
The terms of the agreement will see Novo paying up to $600 million in upfront, development and commercial milestone payments, as well as tiered royalties on annual net sales of licensed products, to be shared between Metaphore and Flagship
Get help Password recovery Recover your password your email A password will be e-mailed to you
Conclusively, the liver might contribute to the development of metabolic syndrome and morphologic changes in hepatic tissue are a result of increased body mass
In seeking to identify existing drugs with anti-fibrotic potential that could be repurposed, incretin receptor agonists, namely the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists, are emerging as candidates
US$ 20.76
US$ 29.22
US$ 22.85
US$ 28.82
